{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidyopd3lhu7shbva46ghjxelvsngjxq7e7lxkpc743ejybu6yemyi",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mfvjni46nx42"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreieuqthmt5jwbknwllfgdqstit63bzjz6k7xa6muoi67dwdsyjwtke"
    },
    "mimeType": "image/jpeg",
    "size": 167582
  },
  "path": "/pharmalot/2026/02/27/pharma-medicines-hospitals-340b-minnesota-report/?utm_campaign=rss",
  "publishedAt": "2026-02-27T21:53:28.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharmalot",
    "340B",
    "hospitals",
    "Pharmaceuticals",
    "STAT+"
  ],
  "textContent": "Minnesota hospitals and clinics participating in a controversial U.S. drug discount program reaped at least $1.34 billion in revenue in 2024.",
  "title": "STAT+: Minnesota report shows large hospitals continue to dominate the 340B drug discount program",
  "updatedAt": "2026-02-27T23:47:08.000Z"
}